0 CHECKOUT

AIDS - Related Kaposi's Sarcoma - Pipeline Review, H2 2015

  • ID: 3384920
  • July 2015
  • 57 pages
  • Global Markets Direct
1 of 4

FEATURED COMPANIES

  • Aphios Corporation
  • AstraZeneca Plc
  • Biogenomics Limited
  • CytRx Corporation
  • MORE

AIDS - Related Kaposi's Sarcoma - Pipeline Review, H2 2015

Summary

The report ‘AIDS - Related Kaposi's Sarcoma - Pipeline Review, H2 2015’, provides an overview of the AIDS - Related Kaposi's Sarcoma’s therapeutic pipeline.

This report provides comprehensive information on the therapeutic development for AIDS - Related Kaposi's Sarcoma, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for AIDS - Related Kaposi's Sarcoma and special features on late-stage and discontinued projects.

The report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Drug profiles/records featured in the report READ MORE >

Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • Aphios Corporation
  • AstraZeneca Plc
  • Biogenomics Limited
  • CytRx Corporation
  • MORE

List of Tables
List of Figures
Introduction
REPORT COVERAGE
AIDS - Related Kaposi's Sarcoma Overview
Therapeutics Development
Pipeline Products for AIDS - Related Kaposi's Sarcoma - Overview
Pipeline Products for AIDS - Related Kaposi's Sarcoma - Comparative Analysis
AIDS - Related Kaposi's Sarcoma - Therapeutics under Development by Companies
AIDS - Related Kaposi's Sarcoma - Pipeline Products Glance
Clinical Stage Products
Early Stage Products
Unknown Stage Products
AIDS - Related Kaposi's Sarcoma - Products under Development by Companies
AIDS - Related Kaposi's Sarcoma - Companies Involved in Therapeutics Development
Aphios Corporation
AstraZeneca Plc
Biogenomics Limited
CytRx Corporation
AIDS - Related Kaposi's Sarcoma - Therapeutics Assessment
Assessment by Monotherapy Products
Assessment by Target
Assessment by Mechanism of Action
Assessment by Route of Administration
Assessment by Molecule Type
Drug Profiles
aldoxorubicin hydrochloride - Drug Profile
Product Description
Mechanism of Action
R&D Progress
CS-TATI-1 - Drug Profile
Product Description
Mechanism of Action
R&D Progress
interferon alfa-2a (recombinant) - Drug Profile
Product Description
Mechanism of Action
R&D Progress
interferon alfa-2b (recombinant) - Drug Profile
Product Description
Mechanism of Action
R&D Progress
paclitaxel nanosomal - Drug Profile
Product Description
Mechanism of Action
R&D Progress
selumetinib sulfate - Drug Profile
Product Description
Mechanism of Action
R&D Progress
AIDS - Related Kaposi's Sarcoma - Recent Pipeline Updates
AIDS - Related Kaposi's Sarcoma - Dormant Projects
AIDS - Related Kaposi's Sarcoma - Dormant Projects
AIDS - Related Kaposi's Sarcoma - Discontinued Products
AIDS - Related Kaposi's Sarcoma - Product Development Milestones
Featured News & Press Releases
Jan 08, 2015: CytRx Announces Positive Interim Phase 2 Aldoxorubicin Results as a Treatment for HIV-Related Kaposi's Sarcoma
Appendix
Methodology
Coverage
Secondary Research
Primary Research
Expert Panel Validation
Contact Us
Disclaimer

List of Tables
Number of Products under Development for AIDS - Related Kaposi's Sarcoma, H2 2015
Number of Products under Development for AIDS - Related Kaposi's Sarcoma - Comparative Analysis, H2 2015
Number of Products under Development by Companies, H2 2015
Comparative Analysis by Clinical Stage Development, H2 2015
Comparative Analysis by Early Stage Development, H2 2015
Comparative Analysis by Unknown Stage Development, H2 2015
Products under Development by Companies, H2 2015
AIDS - Related Kaposi's Sarcoma - Pipeline by Aphios Corporation, H2 2015
AIDS - Related Kaposi's Sarcoma - Pipeline by AstraZeneca Plc, H2 2015
AIDS - Related Kaposi's Sarcoma - Pipeline by Biogenomics Limited, H2 2015
AIDS - Related Kaposi's Sarcoma - Pipeline by CytRx Corporation, H2 2015
Assessment by Monotherapy Products, H2 2015
Number of Products by Stage and Target, H2 2015
Number of Products by Stage and Mechanism of Action, H2 2015
Number of Products by Stage and Route of Administration, H2 2015
Number of Products by Stage and Molecule Type, H2 2015
AIDS - Related Kaposi's Sarcoma Therapeutics - Recent Pipeline Updates, H2 2015
AIDS - Related Kaposi's Sarcoma - Dormant Projects, H2 2015
AIDS - Related Kaposi's Sarcoma - Discontinued Products, H2 2015

List of Figures
Number of Products under Development for AIDS - Related Kaposi's Sarcoma, H2 2015
Number of Products under Development for AIDS - Related Kaposi's Sarcoma - Comparative Analysis, H2 2015
Number of Products under Development by Companies, H2 2015
Comparative Analysis by Clinical Stage Development, H2 2015
Comparative Analysis by Early Stage Products, H2 2015
Assessment by Monotherapy Products, H2 2015
Number of Products by Top 10 Targets, H2 2015
Number of Products by Stage and Top 10 Targets, H2 2015
Number of Products by Top 10 Mechanism of Actions, H2 2015
Number of Products by Stage and Top 10 Mechanism of Actions, H2 2015
Number of Products by Top 10 Routes of Administration, H2 2015
Number of Products by Stage and Top 10 Routes of Administration, H2 2015
Number of Products by Top 10 Molecule Types, H2 2015
Number of Products by Stage and Top 10 Molecule Types, H2 2015

Note: Product cover images may vary from those shown
3 of 4

Aphios Corporation
AstraZeneca Plc
Biogenomics Limited
CytRx Corporation

Note: Product cover images may vary from those shown
4 of 4
Note: Product cover images may vary from those shown

PURCHASING OPTIONS

HAVE A QUESTION?

EMAIL US VIEW FAQs

RELATED PRODUCTS from Db

Our Clients

  • Genentech, Inc.
  • GlaxoSmithKline PLC
  • Maquet Getinge Group
  • Emergent BioSolutions, Inc.
  • Aicuris GmbH & Co.KG
  • Merck & Co., Inc.